Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Melanoma: HELP
Hyun-Il Cho
Based on 11 articles published since 2009
(Why 11 articles?)
||||
Expertise Level
The expertise of Hyun-Il Cho ranks in the
  • Top 2.3%
  • ... of 182,892 published authors worldwide on Melanoma
  • ... from 2009 through 2019
  • ... based on contributions to 11 articles on the topic.
Graphical view (beta)
Work Locations
Details
Most likely:    Catholic University of Korea      
2017
  • Cancer Immunology, Inflammation and Tolerance Program, Augusta University, Georgia Cancer Center, Augusta, Georgia. · Department of Innovative Research for Diagnosis and Treatment of Head & Neck Cancer, Asahikawa Medical University, Asahikawa, Japan. · Department of Pathology, Asahikawa Medical University, Asahikawa, Japan. · Department of Otolaryngology, Head and Neck Surgery, Asahikawa Medical University, Asahikawa, Japan. · Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia. · Children's Healthcare of Atlanta, Atlanta, Georgia. · Catholic Hematopoietic Stem Cell Bank, College of Medicine, The Catholic University of Korea, Seoul, Korea. · Cancer Immunology, Inflammation and Tolerance Program, Augusta University, Georgia Cancer Center, Augusta, Georgia. · Pubmed 27941004
2016
  • Department of Microbiology and Immunology, College of Medicine, The Catholic University of Korea, Seoul 137-701, South Korea. · Catholic Hematopoietic Stem Cell Bank, College of Medicine, The Catholic University of Korea, Seoul 137-701, South Korea. · Catholic Cancer Research Institute, College of Medicine, The Catholic University of Korea, Seoul 137-701, South Korea. · Pubmed 27323820
  • Department of Microbiology and Immunology, College of Medicine, The Catholic University of Korea, Seoul 137-701, South Korea. · Catholic Hematopoietic Stem Cell Bank, College of Medicine, The Catholic University of Korea, Seoul 137-701, South Korea; Cancer Research Institute, College of Medicine, The Catholic University of Korea, Seoul 137-701, South Korea. · Catholic Hematopoietic Stem Cell Bank, College of Medicine, The Catholic University of Korea, Seoul 137-701, South Korea. · Department of Microbiology and Immunology, College of Medicine, The Catholic University of Korea, Seoul 137-701, South Korea; Catholic Hematopoietic Stem Cell Bank, College of Medicine, The Catholic University of Korea, Seoul 137-701, South Korea; Cancer Research Institute, College of Medicine, The Catholic University of Korea, Seoul 137-701, South Korea. Electronic address: · Pubmed 26828454
2015
  • Catholic Hematopoietic Stem Cell Bank; College of Medicine; The Catholic University of Korea ; Seoul, Korea ; Cancer Research Institute; College of Medicine; The Catholic University of Korea ; Seoul, Korea. · Catholic Hematopoietic Stem Cell Bank; College of Medicine; The Catholic University of Korea ; Seoul, Korea. · Cancer Immunology; Inflammation and Tolerance Program; Georgia Regents University Cancer Center ; Augusta, GA USA. · Catholic Hematopoietic Stem Cell Bank; College of Medicine; The Catholic University of Korea ; Seoul, Korea ; Cancer Research Institute; College of Medicine; The Catholic University of Korea ; Seoul, Korea ; College of Medicine; The Catholic University of Korea ; Seoul, South Korea. · Pubmed 26451316
2014
  • Department of Microbiology and Immunology, College of Medicine, The Catholic University of Korea, Seoul 137-701, South Korea. · Catholic Hematopoietic Stem Cell Bank, College of Medicine, The Catholic University of Korea, Seoul 137-701, South Korea. · Department of Hematology, Catholic Blood and Marrow Transplantation Center, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 137-701, South Korea. · Catholic Hematopoietic Stem Cell Bank, College of Medicine, The Catholic University of Korea, Seoul 137-701, South Korea; Cancer Research Institute, College of Medicine, The Catholic University of Korea, Seoul 137-701, South Korea. Electronic address: · Department of Microbiology and Immunology, College of Medicine, The Catholic University of Korea, Seoul 137-701, South Korea; Catholic Hematopoietic Stem Cell Bank, College of Medicine, The Catholic University of Korea, Seoul 137-701, South Korea. Electronic address: · Pubmed 25444817
Probable:    University of South Florida   Contact    
2013
  • Whitehead Institute for Biomedical Research, 9 Cambridge Center, Cambridge, MA 02142. · Whitehead Institute for Biomedical Research, 9 Cambridge Center, Cambridge, MA 02142 ; Department of Medicine, Massachusetts General Hospital, Boston, MA. · Whitehead Institute for Biomedical Research, 9 Cambridge Center, Cambridge, MA 02142 ; Massachusetts Institute of Technology, Cambridge, MA. · Whitehead Institute for Biomedical Research, 9 Cambridge Center, Cambridge, MA 02142 ; University of Cincinnati, 2600 Clifton Ave, Cincinnati, OH 45221. · Whitehead Institute for Biomedical Research, 9 Cambridge Center, Cambridge, MA 02142 ; Janssen Research and Development, division of Janssen Pharmaceutica NV, Turnhoutseweg 30, Beerse B2340, Belgium. · Dept. of Immunology, H. Lee Moffitt Cancer Center & Research Institute, 12902 Magnolia Drive, Tampa, FL 33612. · Pubmed 24459675
  • Immunology Program, Moffitt Cancer Center, Tampa, FL 33612, USA. · Pubmed 23266830
2012
  • Immunology Program, Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, FL 33612, USA. · Pubmed 22367213
  • Cancer Vaccine Group, Immunology Program, Moffitt Cancer Center, 12902 Magnolia Drive, SRB2, Tampa, FL 33612, USA. · Pubmed 21915800
2011
  • Immunology Program, Moffitt Cancer Center, Tampa, FL 33612, USA. · Pubmed 20889921
2009
  • Immunology Program, Moffitt Cancer Center, and Department of Oncologic Sciences, University of South Florida, Tampa, Florida, USA. · Pubmed 19903852
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 11 total) written by Hyun-Il Cho about Melanoma:

  • Optimization of Peptide Vaccines to Induce Robust Antitumor CD4 T-cell Responses. 2017
  • Co-expression of CD40L with CD70 or OX40L increases B-cell viability and antitumor efficacy. 2016
  • Zoledronic acid induces dose-dependent increase of antigen-specific CD8 T-cell responses in combination with peptide/poly-IC vaccine. 2016
  • An optimized peptide vaccine strategy capable of inducing multivalent CD8 2015
  • CD4 T-cells transduced with CD80 and 4-1BBL mRNA induce long-term CD8 T-cell responses resulting in potent antitumor effects. 2014
  • Transnuclear TRP1-specific CD8 T cells with high or low affinity TCRs show equivalent antitumor activity. 2013
  • BiVax: a peptide/poly-IC subunit vaccine that mimics an acute infection elicits vast and effective anti-tumor CD8 T-cell responses. 2013
  • A potent vaccination strategy that circumvents lymphodepletion for effective antitumor adoptive T-cell therapy. 2012
  • Design of immunogenic and effective multi-epitope DNA vaccines for melanoma. 2012
  • Interferon γ limits the effectiveness of melanoma peptide vaccines. 2011
Show List of Full Article Records
Google Searches

Learn more about Hyun-Il Cho using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Catholic University of Korea
University of South Florida
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Catholic University of Korea
2017
  • Cancer Immunology, Inflammation and Tolerance Program, Augusta University, Georgia Cancer Center, Augusta, Georgia. · Department of Innovative Research for Diagnosis and Treatment of Head & Neck Cancer, Asahikawa Medical University, Asahikawa, Japan. · Department of Pathology, Asahikawa Medical University, Asahikawa, Japan. · Department of Otolaryngology, Head and Neck Surgery, Asahikawa Medical University, Asahikawa, Japan. · Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia. · Children's Healthcare of Atlanta, Atlanta, Georgia. · Catholic Hematopoietic Stem Cell Bank, College of Medicine, The Catholic University of Korea, Seoul, Korea. · Cancer Immunology, Inflammation and Tolerance Program, Augusta University, Georgia Cancer Center, Augusta, Georgia. · Pubmed 27941004
2016
  • Department of Microbiology and Immunology, College of Medicine, The Catholic University of Korea, Seoul 137-701, South Korea. · Catholic Hematopoietic Stem Cell Bank, College of Medicine, The Catholic University of Korea, Seoul 137-701, South Korea. · Catholic Cancer Research Institute, College of Medicine, The Catholic University of Korea, Seoul 137-701, South Korea. · Pubmed 27323820
  • Department of Microbiology and Immunology, College of Medicine, The Catholic University of Korea, Seoul 137-701, South Korea. · Catholic Hematopoietic Stem Cell Bank, College of Medicine, The Catholic University of Korea, Seoul 137-701, South Korea; Cancer Research Institute, College of Medicine, The Catholic University of Korea, Seoul 137-701, South Korea. · Catholic Hematopoietic Stem Cell Bank, College of Medicine, The Catholic University of Korea, Seoul 137-701, South Korea. · Department of Microbiology and Immunology, College of Medicine, The Catholic University of Korea, Seoul 137-701, South Korea; Catholic Hematopoietic Stem Cell Bank, College of Medicine, The Catholic University of Korea, Seoul 137-701, South Korea; Cancer Research Institute, College of Medicine, The Catholic University of Korea, Seoul 137-701, South Korea. Electronic address: · Pubmed 26828454
2015
  • Catholic Hematopoietic Stem Cell Bank; College of Medicine; The Catholic University of Korea ; Seoul, Korea ; Cancer Research Institute; College of Medicine; The Catholic University of Korea ; Seoul, Korea. · Catholic Hematopoietic Stem Cell Bank; College of Medicine; The Catholic University of Korea ; Seoul, Korea. · Cancer Immunology; Inflammation and Tolerance Program; Georgia Regents University Cancer Center ; Augusta, GA USA. · Catholic Hematopoietic Stem Cell Bank; College of Medicine; The Catholic University of Korea ; Seoul, Korea ; Cancer Research Institute; College of Medicine; The Catholic University of Korea ; Seoul, Korea ; College of Medicine; The Catholic University of Korea ; Seoul, South Korea. · Pubmed 26451316
2014
  • Department of Microbiology and Immunology, College of Medicine, The Catholic University of Korea, Seoul 137-701, South Korea. · Catholic Hematopoietic Stem Cell Bank, College of Medicine, The Catholic University of Korea, Seoul 137-701, South Korea. · Department of Hematology, Catholic Blood and Marrow Transplantation Center, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 137-701, South Korea. · Catholic Hematopoietic Stem Cell Bank, College of Medicine, The Catholic University of Korea, Seoul 137-701, South Korea; Cancer Research Institute, College of Medicine, The Catholic University of Korea, Seoul 137-701, South Korea. Electronic address: · Department of Microbiology and Immunology, College of Medicine, The Catholic University of Korea, Seoul 137-701, South Korea; Catholic Hematopoietic Stem Cell Bank, College of Medicine, The Catholic University of Korea, Seoul 137-701, South Korea. Electronic address: · Pubmed 25444817
University of South Florida
2013
  • Whitehead Institute for Biomedical Research, 9 Cambridge Center, Cambridge, MA 02142. · Whitehead Institute for Biomedical Research, 9 Cambridge Center, Cambridge, MA 02142 ; Department of Medicine, Massachusetts General Hospital, Boston, MA. · Whitehead Institute for Biomedical Research, 9 Cambridge Center, Cambridge, MA 02142 ; Massachusetts Institute of Technology, Cambridge, MA. · Whitehead Institute for Biomedical Research, 9 Cambridge Center, Cambridge, MA 02142 ; University of Cincinnati, 2600 Clifton Ave, Cincinnati, OH 45221. · Whitehead Institute for Biomedical Research, 9 Cambridge Center, Cambridge, MA 02142 ; Janssen Research and Development, division of Janssen Pharmaceutica NV, Turnhoutseweg 30, Beerse B2340, Belgium. · Dept. of Immunology, H. Lee Moffitt Cancer Center & Research Institute, 12902 Magnolia Drive, Tampa, FL 33612. · Pubmed 24459675
  • Immunology Program, Moffitt Cancer Center, Tampa, FL 33612, USA. · Pubmed 23266830
2012
  • Immunology Program, Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, FL 33612, USA. · Pubmed 22367213
  • Cancer Vaccine Group, Immunology Program, Moffitt Cancer Center, 12902 Magnolia Drive, SRB2, Tampa, FL 33612, USA. · Pubmed 21915800
2011
  • Immunology Program, Moffitt Cancer Center, Tampa, FL 33612, USA. · Pubmed 20889921
2009
  • Immunology Program, Moffitt Cancer Center, and Department of Oncologic Sciences, University of South Florida, Tampa, Florida, USA. · Pubmed 19903852
Yearly article counts 00121122101
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.